Cleveland-Cliffs
CLF
$12.12
-0.25%
Cleveland-Cliffs Inc. is a vertically integrated North American flat-rolled steel producer and iron ore pellet manufacturer, operating blast furnaces, direct reduced iron (DRI) facilities, scrap processing, and downstream stamping, tooling, and tubular finishing assets, with the United States serving as its dominant market and the automotive sector as its largest end customer. As one of the largest flat-rolled steel suppliers in North America and the region's largest producer of iron ore pellets, Cliffs occupies a scale-driven, vertically integrated position in a highly cyclical, capital-intensive commodity industry where cost position and trade protection largely determine profitability. The current investor narrative centers on a violent earnings recovery: after a brutal stretch of quarterly losses through 2025, Q2 2026 delivered a return to positive operating income and a sharp EBITDA rebound, prompting management to roughly double EBITDA guidance on robust domestic steel demand and pricing. This turnaround is being amplified by tariff-driven import protection and a reported $1 billion investment in a flagship plant, but the debate remains fierce over whether the recovery is durable or a tariff-fueled headwind-dependent bounce, with the stock still deeply negative over the trailing year and analysts split between bulls and skeptics.…
CLF
Cleveland-Cliffs
$12.12
Related headlines
CLF 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cleveland-Cliffs's 12-month outlook, with a consensus price target around $12.60 and implied upside of +4.0% versus the current price.
Average Target
$12.60
0 analysts
Implied Upside
+4.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$10 - $15
Analyst target range
Ten analysts cover Cleveland-Cliffs with a consensus recommendation of "hold" (mean rating 2.77 on a scale where 1 is strong buy and 5 is strong sell), and an average target price of $12.60 — implying just +3.96% upside from the current $12.12. The distribution skews cautious: recent actions include Barclays maintaining Underweight, Wells Fargo and JP Morgan at Equal Weight/Neutral, B of A at Neutral, with only GLJ Research carrying a Buy (upgraded from Neutral in July 2026). Consensus is best characterized as neutral-to-cautious, with the stock trading essentially at fair value per the Street.
The target range of $10.00 to $15.00 is moderately wide relative to the $12.60 midpoint, signaling meaningful disagreement about the durability of the steel recovery. The $15.00 high target implies multiple expansion on sustained tariff-protected pricing and successful execution of the $1 billion plant investment driving EBITDA toward guidance; the $10.00 low target prices in margin compression, competitive share loss to lower-cost EAF producers, and renewed pricing weakness. Notably, consensus FY revenue of $22.22 billion (range $21.05–$23.06 billion) and EPS of $0.894 (range $0.833–$0.939) imply analysts expect a full-year profit despite the first-half losses — a forecast that hinges entirely on the second-half recovery holding, leaving the stock acutely sensitive to the next quarterly print and any shift in trade policy.
Drowning in data?
Find the real signal!
Bulls vs Bears: CLF Investment Factors
The bear case currently has stronger evidence on hard financials — negative trailing margins, -$857 million FCF, interest expense at 11x operating income, and a Street consensus of hold with only 3.96% implied upside — while the bull case rests on a genuine but single-quarter inflection (EBITDA from -$76 million to $329 million) plus tariff support and a doubled guidance. The stock's 0.35x sales multiple is near the bottom of its historical range, so pessimism is already substantially priced; the question is whether the Q2 recovery is the first leg of a cycle or a tariff-dependent bounce. The single most important tension is the durability of tariff-protected domestic steel pricing: if flat-rolled prices hold through the next two quarters, the forward PE of 12.76x on $0.894 EPS becomes a value entry, but if pricing rolls over, the interest burden reasserts itself and the equity retests single digits. Momentum has also deteriorated (1-month relative strength -1.47% after +27.91% over three months), suggesting the easy part of the recovery trade is done.
Bullish
- Q2 EBITDA inflected to $329M: Q2 2026 EBITDA of $329 million compares with $100 million in Q1 2026 and -$76 million in Q2 2025, a swing of roughly $405 million year-over-year. Operating income turned positive at $14 million versus -$207 million sequentially, and gross margin recovered from -1.67% to +3.73%, evidence that the operating leverage in the vertically integrated model is finally working in the company's favor.
- Management roughly doubled EBITDA guidance: Following Q2 results, management roughly doubled its EBITDA guidance on robust domestic steel demand and pricing, and the July 23 news flow explicitly tied the stock's surge to that guidance raise. If even the low end of the raised guidance is delivered, the forward PE of 12.76x on consensus FY EPS of $0.894 would look reasonable rather than stretched for a cyclical at an earnings trough.
- Deep discount on sales and book value: CLF trades at 0.35x sales and 0.77x EV/Sales versus a historical steel-sector norm of roughly 0.6-1.0x, and at 1.07x book versus a historical range of roughly 0.65x-2.65x. Its own PS ratio has ranged from about 0.65x to 2.8x over recent years, so the current multiple sits near the absolute bottom of the band — the market is pricing persistent skepticism that a durable recovery would quickly invalidate.
- Tariff protection plus $1B plant investment: Tariff-driven import protection supports domestic flat-rolled pricing, and the reported $1 billion investment in the flagship plant (the August 21 catalyst behind the stock pop) targets cost position and volume capability. With Steelmaking at $5.052 billion of Q2's $5.226 billion revenue, any structural improvement in domestic price realization flows almost entirely to the equity.
Bearish
- Still unprofitable with -7.94% net margin: Despite the Q2 inflection, net income was -$145 million (EPS -$0.25), trailing net margin is -7.94%, gross margin -4.10%, and ROE is -24.17%. Q2's 3.73% gross margin is far below the high-single-to-low-double-digit levels normal for a healthy steel cycle, so the company remains structurally unprofitable at current pricing.
- Interest expense dwarfs operating income: Q2 interest expense of $156 million consumed more than ten times the quarter's $14 million of operating income, and debt-to-equity is 1.336 with total debt at 57.9% of capitalization. The capital structure, not the steel market, is the binding constraint on equity value — a $1 billion plant investment must be funded against a balance sheet already carrying this load.
- Negative $857M trailing free cash flow: Trailing free cash flow is -$857 million, the PCF ratio is -14.15, and cash on hand was only $70 million at quarter-end. Q1 2026 required $454 million of net financing inflows to bridge a -$477 million FCF quarter, meaning the company depends on external capital markets rather than internal cash generation — a fragile position if credit conditions tighten.
- Analysts see only 3.96% upside: The consensus rating is "hold" (mean 2.77) with an average target of $12.60 versus the $12.12 price, and recent actions skew cautious: Barclays Underweight, Wells Fargo and JPMorgan Equal Weight/Neutral, BofA Neutral, with only GLJ Research at Buy. The $10.00 low target implies roughly -17.5% downside if the recovery stalls.
CLF Technical Analysis
Cleveland-Cliffs is in a volatile, range-bound recovery phase rather than a clean uptrend: the stock is down 10.62% over the trailing year and 10.88% year-to-date, yet has rallied 30.60% over the past three months and 21.93% over six months. At $12.12, the shares sit at roughly 49.1% of the 52-week range between a low of $7.73 and a high of $16.70 — dead center of the band, which signals indecision and two-way risk rather than momentum-driven overextension or a falling-knife setup. The 1-year relative strength of -26.15% versus the S&P 500 confirms persistent structural underperformance despite the recent bounce.
Short-term momentum has clearly decelerated: the stock is down 0.25% over the past month while the S&P 500 gained 1.22%, producing a relative strength of -1.47%, a sharp reversal from the +27.91% three-month relative strength that made CLF a standout performer in the summer. This divergence — strong 3-month gains but a flat-to-negative 1-month trend — suggests the July–September rally (which peaked near $12.87 on September 23) is consolidating rather than accelerating, with the October 9 spike to $12.98 failing to hold and price fading to $12.12. The pattern looks like mean reversion after a sharp run rather than a confirmed trend reversal, but the loss of momentum argues against chasing strength at current levels.
Key technical levels are well defined: resistance sits at the recent swing high of $12.98 and, more meaningfully, the 52-week high of $16.70, while support rests at the September pullback low near $11.01 and the 52-week low of $7.73. A breakout above $12.98 on volume would validate the recovery thesis and open a path toward the mid-teens, whereas a breakdown below $11.00 would signal the summer rally has failed and refocus attention on the single-digit lows. With a beta of 2.093 — roughly 109% more volatile than the market — and a maximum drawdown of -51.67%, position sizing must account for violent two-way swings; a 5.64 short ratio also flags meaningful bearish positioning that can fuel squeezes in either direction.
Beta
2.09
2.09x market volatility
Max Drawdown
-51.7%
Largest decline past year
52-Week Range
$8-$17
Price range past year
Annual Return
-10.6%
Cumulative gain past year
| Period | CLF Return | S&P 500 |
|---|---|---|
| 1m | -0.2% | +0.2% |
| 3m | +30.6% | +2.9% |
| 6m | +21.9% | +8.4% |
| 1y | -10.6% | +14.9% |
| ytd | -10.9% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CLF Fundamental Analysis
Revenue is growing modestly but the trajectory is improving: Q2 2026 revenue of $5.226 billion rose 5.92% year-over-year versus $4.934 billion in Q2 2025, and marked a sequential acceleration from Q1 2026's $4.922 billion and Q4 2025's $4.313 billion. The Steelmaking segment dominates the mix at $5.052 billion of the quarter's total, with Other Businesses contributing just $339 million, so the entire investment case hinges on flat-rolled steel pricing and automotive demand. The multi-quarter trend — from $4.629 billion in Q1 2025 to $5.226 billion in Q2 2026 — shows a steady top-line rebuild, but growth remains pricing-led and cyclical rather than structural, leaving revenue highly sensitive to tariff policy and auto production volumes.
Profitability has inflected but remains fragile: Q2 2026 net income was -$145 million (EPS -$0.25), a dramatic narrowing from -$483 million in Q2 2025 and -$237 million in Q1 2026, while gross margin swung from -1.67% in Q1 2026 to +3.73% in Q2 and operating income turned positive at $14 million versus -$207 million the prior quarter. EBITDA of $329 million in Q2 compares with $100 million in Q1 and -$76 million a year ago, a genuine operating recovery, yet the trailing net margin of -7.94% and gross margin of -4.10% underscore that the company is not yet sustainably profitable. For a commodity steelmaker, gross margins in the high single to low double digits are the norm in healthy cycles, so current levels remain far below normalized profitability.
Financial health is the key risk: debt-to-equity stands at 1.336 with total debt at 57.9% of capitalization, interest expense of $156 million in Q2 consumed more than ten times the quarter's $14 million operating income, and trailing free cash flow is -$857 million. Liquidity is adequate — current ratio of 1.95 and quick ratio of 0.63 — but cash on hand was only $70 million at quarter-end, and Q1 2026 required $454 million of net financing inflows to bridge a -$477 million FCF quarter. ROE of -24.17% and ROA of -1.71% confirm capital destruction, and with a PCF ratio of -14.15, the company depends on external financing and cyclical cash swings rather than internally generated funds to support its $1 billion plant investment.
Quarterly Revenue
$5.2B
2026-06
Revenue YoY Growth
+5.9%
YoY Comparison
Gross Margin
3.7%
Latest Quarter
Free Cash Flow
$-857000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CLF Overvalued?
Because trailing net income is negative (EPS -$0.226), the PE ratio of -4.43x is meaningless and I have selected the price-to-sales ratio as the primary metric, supplemented by EV/Sales given negative EBITDA on a trailing basis (EV/EBITDA of -83.71x). CLF trades at 0.35x sales and 0.77x EV/Sales — optically cheap — while the forward PE of 12.76x against consensus FY EPS of $0.894 implies the market is pricing a full earnings recovery; the enormous gap between the negative trailing multiple and the positive forward multiple captures the entire bull-bear debate in a single number.
On a peer basis, the 0.35x PS ratio is well below the historical steel-sector norm of roughly 0.6–1.0x and far beneath CLF's own long-run average, while the 1.07x price-to-book sits near the low end of its range; the discount reflects negative margins (net margin -7.94%, operating margin -7.29%) and a leveraged balance sheet rather than superior growth. Relative to integrated and EAF peers that have maintained positive margins through the downturn, Cliffs screens as a deep-value, high-beta cyclical — cheap only if the earnings recovery materializes, expensive if steel pricing rolls over.
Historically, CLF's PS ratio has ranged from roughly 0.65x to 2.8x over the past several years, with the current 0.35x near the absolute bottom of that band, and its PB ratio has traded between roughly 0.65x and 2.65x versus 1.07x today. The market is therefore pricing in persistent skepticism — either a value opportunity if the Q2 EBITDA inflection proves durable, or justified caution given four consecutive years of negative free cash flow and a debt load that consumes operating income through interest expense.
PE
-4.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 2x~12x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-83.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are dominated by the balance sheet. Debt-to-equity of 1.336 with total debt at 57.9% of capitalization produced $156 million of Q2 interest expense against just $14 million of operating income — a coverage ratio of roughly 0.09x on an operating basis — while trailing free cash flow is -$857 million and cash on hand was only $70 million. Revenue concentration compounds this: Steelmaking generated $5.052 billion of Q2's $5.226 billion, with automotive as the largest end market, so a single demand shock in flat-rolled steel or auto production hits essentially the entire top line, and the 5.92% YoY revenue growth is pricing-led rather than structural.
Market and competitive risks center on valuation compression and the cost-curve gap. At 0.35x sales and 1.07x book the stock is optically cheap, but the forward PE of 12.76x already discounts a full recovery to $0.894 EPS, so any shortfall forces multiple compression on top of earnings disappointment. The April 2026 coverage explicitly noted tariffs amplifying the gap between efficient, flexible producers and those burdened by high fixed costs — Steel Dynamics spiked on record shipments while Cliffs struggled — and with a beta of 2.093, roughly 109% more volatile than the market, CLF amplifies any sector rotation or macro risk-off move. Trade policy is a two-sided risk: tariff relief or removal would cut both ways for domestic pricing.
In the worst case, a rollover in flat-rolled pricing into Q3/Q4 2026 would reverse the EBITDA inflection, push the company back toward the -$76 million to $100 million EBITDA range, and refocus the market on the -$857 million FCF and interest burden. The stock's 52-week low of $7.73 represents roughly -36% from $12.12, and the analyst low target of $10.00 implies about -17.5%; the historical maximum drawdown of -51.67% shows how far a high-beta cyclical can fall in a genuine downcycle. A realistic adverse scenario is a retest of the $10.00 low target first, with a break below $11.00 technical support opening the path toward the high single digits.
